Moderna announce Health Canada approval for updated COVID-19 vaccine

Moderna announced that Health Canada has authorized its updated COVID-19 vaccine, SPIKEVAX KP.2 variant, to help prevent COVID-19 in individuals six months of age and older. Moderna’s updated COVID-19 vaccine targets the KP.2 sub-lineage of SARS-CoV-2. With vaccines ready, Moderna will begin delivery of updated doses to the Public Health Agency of Canada, ensuring supply is available in time for provincial and territorial vaccination campaigns. “As we face another critical season in the fight against COVID-19, we remain steadfast in our dedication to delivering innovative solutions that help protect communities,” said Stephane Bancel, CEO of Moderna. “The authorization of our updated COVID-19 vaccine by Health Canada ensures that Canadians have timely access to the latest vaccines, helping them to stay protected during the upcoming fall and winter months.”